Evidence map›Paper›PMID 30598040›Full record

ArticleMolecules (Basel, Switzerland)2018

Modulation of Skin Inflammatory Response by Active Components of Silymarin.

Jana Juráňová, Juliette Aury-Landas, Karim Boumediene, Catherine Baugé, David Biedermann, Jitka Ulrichová, Jana Franková

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Liposomal Delivery of a BiotechnologicalAntioxidants (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Silymarin and Inflammation: Food for Thoughts.Antioxidants (Basel, Switzerland) · 2024
    Review
  11. Restoring Activity of Milk Thistle (Animals : an open access journal from MDPI · 2023
    Review
  12. Development of an Effective Acne Treatment Based on CBD and Herbal Extracts: PreliminaryEvidence-based complementary and alternative medicine : eCAM · 2023
    Article
  13. Silver Nanoparticles Prepared UsingJournal of fungi (Basel, Switzerland) · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Assessing Biocompatibility of Face Mask Materials during COVID-19 Pandemic by a Rapid Multi-Assays Strategy.International journal of environmental research and public health · 2021
    Article
  18. Article
  19. The effect ofAging · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jana JuráňováDepartment of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Hněvotínská 3, 775 15 Olomouc, Czech Republic. janajuranova@centrum.cz.
Juliette Aury-LandasEA7451 BioConnecT, Normandie University, UNICAEN, 14000 Caen, France. juliette.aury-landas@unicaen.fr.
Karim BoumedieneEA7451 BioConnecT, Normandie University, UNICAEN, 14000 Caen, France. karim.boumediene@unicaen.fr.
Catherine BaugéEA7451 BioConnecT, Normandie University, UNICAEN, 14000 Caen, France. catherine.bauge@unicaen.fr.
David BiedermannInstitute of Microbiology of the Czech Academy of Sciences, Laboratory of Biotransformation, Vídeňská 1083, 14220 Praha 4, Czech Republic. david.biedermann@gmail.com.
Jitka UlrichováDepartment of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Hněvotínská 3, 775 15 Olomouc, Czech Republic. jitkaulrichova@seznam.cz.
Jana FrankováDepartment of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Hněvotínská 3, 775 15 Olomouc, Czech Republic. frankova0@seznam.cz.ORCID 0000-0002-9344-3569
Institute of Molecular and Translational Medicine · CZNormandie Université · FRCzech Academy of Sciences · CZ

Funding

Czech Science Foundation 18-00132SPalacky University, Czech Republic IGA_LF_2017_011Youth and Sports of the Czech Republic LO1304
6 · The paper itself

Abstract

In this study, we compared selected silymarin components, such as quercetin (QE), 2,3-dehydrosilybin (DHS) and silybin (SB), with the anti-inflammatory drug indomethacin (IND) in terms of their wound healing potential. In view of the fact that pathological cutaneous wound healing is associated with persistent inflammation, we studied their anti-inflammatory activity against inflammation induced by bacterial lipopolysaccharide (LPS). We investigated the regulation of crucial pro-inflammatory transcription factors-nuclear factor kappa-B (NF-κB) and activator protein 1 (AP-1)-as well as the expression of downstream inflammatory targets by Western blotting, real-time PCR (RT-PCR), electrophoretic mobility shift assay (EMSA), and/or enzyme-linked immunosorbent assay (ELISA) in vitro using primary normal human dermal fibroblasts (NHDF). We demonstrated the greater ability of DHS to modulate the pro-inflammatory cytokines production via the NF-κB and AP-1 signaling pathways when compared to other tested substances. The prolonged exposure of LPS-challenged human dermal fibroblasts to DHS had both beneficial and detrimental consequences. DHS diminished interleukin-6 (IL-6) and interleukin-8 (IL-8) secretion but induced the significant upregulation of IL-8 mRNA associated with NF-κB and AP-1 activation. The observed conflicting results may compromise the main expected benefit, which is the acceleration of the healing of the wound via a diminished inflammation.

Indexed as

Anti-Inflammatory AgentsCell ProliferationChemokinesCytokinesDermatitisFibroblastsGene ExpressionHumansLipopolysaccharidesNF-kappa BRNA, MessengerSilymarinWound HealingAnti-Inflammatory AgentsChemokinesCytokinesLipopolysaccharidesNF-kappa BRNA, MessengerSilymarincytokinesfibroblastsinflammationNF-κBskin wound healing

Identifiers

PMID30598040
PMCPMC6337225
OpenAlexW2907828826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.